Internal Medicine, Cardiovascular Disease · Englewood, FL
NPI
1295870087
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2691 Placida Rd Ste 5
Englewood, FL, 34224
Phone (941) 280-0499
Groups this clinician bills Medicare through
Medicare paid, 2024
$511K
10,158 services
Medicare patients, 2024
1,577
Average age 79
Drug cost, 2024
$1.6M
8,524 prescriptions
Company payments, 2025
$122
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth W Pfahler was code 93298 (external electrocardiographic monitoring), 1,213 times for 146 patients. In total Kenneth W Pfahler billed 10,158 services in 53 codes, and Medicare paid $511K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93298 External Electrocardiographic Monitoring | Office | 1,213 | 146 | $20.43 | $25K |
| 93000 Electrocardiogram | Office | 1,077 | 718 | $10.37 | $11K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,040 | 260 | $5.45 | $5,664 |
| 99214 Office E&M - Established | Office | 759 | 554 | $89.27 | $68K |
| 93010 Electrocardiogram | Facility | 711 | 330 | $6.26 | $4,453 |
| 99211 Office E&M - Established | Office | 684 | 124 | $15.88 | $11K |
| 85610 Clinical Chemistry | Office | 578 | 61 | $4.20 | $2,428 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 568 | 284 | $92.40 | $52K |
| 93306 Echocardiography (TTE/TEE) | Office | 408 | 407 | $131.52 | $54K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 347 | 346 | $129.60 | $45K |
| 93306 Echocardiography (TTE/TEE) | Facility | 320 | 305 | $52.38 | $17K |
| 93294 External Electrocardiographic Monitoring | Office | 294 | 157 | $20.26 | $5,958 |
| 78452 Myocardial Perfusion Scan | Office | 284 | 284 | $313.69 | $89K |
| 93015 Electrocardiogram | Office | 284 | 284 | $47.58 | $14K |
| 99223 Hospital E&M - Initial | Facility | 175 | 158 | $134.76 | $24K |
By year: 2022 $655K for 9,956 services; 2023 $635K for 9,975 services; 2024 $511K for 10,158 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 578 | 61 | $4.20 | $2,428 |
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth W Pfahler prescribed most often to Medicare patients was Rosuvastatin Calcium, with 718 prescriptions and refills. In total Kenneth W Pfahler wrote 8,524 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 718 | 2,104 | 237 | $11K |
| Sotalol Sotalol Hcl | 695 | 2,025 | 232 | $19K |
| Eliquis Apixaban | 610 | 1,374 | 189 | $769K |
| Metoprolol Succinate Generic | 488 | 1,400 | 170 | $7,522 |
| Atorvastatin Calcium Generic | 373 | 1,055 | 109 | $3,312 |
| Metoprolol Tartrate Generic | 369 | 1,055 | 119 | $3,059 |
| Clopidogrel Clopidogrel Bisulfate | 283 | 830 | 91 | $3,566 |
| Xarelto Rivaroxaban | 267 | 640 | 76 | $345K |
| Furosemide Generic | 254 | 733 | 88 | $1,512 |
| Lisinopril Generic | 248 | 711 | 81 | $1,546 |
| Losartan Potassium Generic | 239 | 710 | 80 | $2,462 |
| Spironolactone Generic | 237 | 689 | 92 | $2,245 |
| Amlodipine Besylate Generic | 226 | 673 | 78 | $1,217 |
| Carvedilol Generic | 209 | 607 | 72 | $1,410 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 168 | 495 | 55 | $2,995 |
Brand drugs: 1,355 claims; generic drugs: 7,169 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth W Pfahler $122 ($122 in general payments such as food, travel and fees) from 4 companies. The largest payer was Novo Nordisk Inc with $50.95.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.